Nanobots in bloodstream by 2020s

Legacy lead · see outcome dispositionResearch snapshot · October 15, 2026

Original intake · research history. This lead is preserved as imported. It is not scored or redirected. QUARANTINE RELATED VERSION ONLY

An alleged 2020 blood-nanobot forecast needs its own source; related 2029 article claim does not settle it.

Attribution unresolved — outcome conditional on this wording

Clinical medical nanobots circulate in patients by 2020.

Conditional verdict: WRONG

At original deadline: NOT FULFILLED · By review: NOT FULFILLED

The clinical review describes translation hurdles rather than a routine autonomous bloodstream-robot capability. This 2020 lead is assessed conditionally and is not merged into the sourced 2029 version.

Excluded from aggregate author accuracy. Conditional wording and related canonical versions are never counted twice.

N29

Reconciled records & related versions

A link can identify a related version, split claim, or unresolved attribution; it does not establish equivalence.

Disposition sources: P02 P04

The original imported lead.

IMPORTED PARAPHRASE · NOT A VERIFIED QUOTATION

Nanobots in bloodstream by 2020s

Singularity Is Near (2005)

2005 · Attribution / year unconfirmed
Page, edition, or timestamp not yet established

No verified source URL recorded

Normalized claim: Not established. The testable claim will be written after the original wording is checked.
Success criteria: Not established. Thresholds, adoption requirements, geography, cost, and required technology must be retained during review.
Claim type: Not classified

Timeline

PREDICTION MADE2005Unconfirmed source year

ORIGINAL TARGET2020No exact deadline used in statistics

FULL REALIZATION—No achievement year established

Outcome at original deadlineUNREVIEWED

Outcome at reviewUNREVIEWED

Supplied target wording: 2020. No confirmed date is used in calculations. Forecast horizon: not established. Drift is a calendar-year difference, not a precise elapsed duration.

The evidence.

No outcome evidence has been verified.

Legacy ratings are preserved in the source package. They have not been accepted as evidence for this assessment.

Capability, adoption, and timing

A related breakthrough is not automatically fulfillment. Review must check the actual capability, how widely it was required to be used, the specified technology, and the original deadline. A prototype cannot establish a claim about routine or widespread use.

Research notes & history

Imported research lead only. Verify attribution, deadline, scope and outcome; do not inherit the legacy score. Draft category needs review.

Open questions

Check the original wording, attribution, and publication date.
Establish the deadline and full success criteria.
Resolve repetitions and related forecast versions.
Find independent evidence for the deadline and review outcomes.

Imported from: kurzweil_prediction_intake_v0_1.csv · CSV row 55
Legacy identifier: DEC-024
Forecast family: Not assigned
Parent statement: DEC-024
File checksum: dcf2f213917bfaccdcdd45a7b98b5db4243cda090687358879d5ed53838f3bb2

Inspect preserved source fields

Record ID: DEC-024
Prediction — imported lead: Nanobots in bloodstream by 2020s
Primary category — draft: Biology & medicine
Subcategory / secondary tags: Biotech
Claimed source — legacy: Singularity Is Near (2005)
Source year — unconfirmed: 2005
Target text — legacy: 2020
Confirmed deadline year: (blank)
At-deadline outcome: UNREVIEWED
Outcome at review: UNREVIEWED
First full-achievement year: (blank)
Review year: 2026
Review state: UNREVIEWED
Canonical for statistics?: NO
Forecast family ID: (blank)
Parent statement ID: DEC-024
Prediction source URL: (blank)
Page / paragraph / timestamp: (blank)
Outcome evidence URLs: (blank)
Success criteria / scope: (blank)
Original wording checked?: NO
Adoption stage / claim type: (blank)
Date precision / target interval: (blank)
Review notes: Imported research lead only. Verify attribution, deadline, scope and outcome; do not inherit the legacy score. Draft category needs review.
Legacy import ID: DEC-024
Display status: UNREVIEWED
Drift — years: (blank)
Overdue — years: (blank)
Due and eligible: 0
On-time full hit: 0
Full realization hit: 0
Publication year confirmed: (blank)

Review history

2026-10-14 — Evidence v0.2: An alleged 2020 blood-nanobot forecast needs its own source; related 2029 article claim does not settle it.

2026-10-15 — QUARANTINE_RELATED_VERSION_ONLY: An alleged 2020 blood-nanobot forecast needs its own source; related 2029 article claim does not settle it. Original record retained; no automatic redirect or score inherited.

Related forecasts.

No forecast family has been resolved for this record. Related statements and revised deadlines will be linked during research.